Deoxynortryptoquivaline: A unique antiprostate cancer agent

The androgen receptor (AR) is a critical target in all the clinical stages of prostate cancer. To identify a new AR inhibitor, we constructed a new screening system using the androgen-dependent growth of prostate cancer cell lines as a screening indicator. We screened 50,000 culture broths of microo...

Descripción completa

Detalles Bibliográficos
Autores principales: YAMAZAKI, YOHKO, KAWADA, MANABU, MOMOSE, ISAO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513949/
https://www.ncbi.nlm.nih.gov/pubmed/37744273
http://dx.doi.org/10.32604/or.2023.030266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513949/
https://www.ncbi.nlm.nih.gov/pubmed/37744273
http://dx.doi.org/10.32604/or.2023.030266

Ejemplares similares